Giacolini T, Alcaro A, Conversi D, Tarsitani L
Front Psychol. 2025; 15():1391664.
PMID: 39834756
PMC: 11743547.
DOI: 10.3389/fpsyg.2024.1391664.
Bogdanov M, Bustamante L, Devine S, Sheldon S, Otto A
J Neurosci. 2025; 45(10).
PMID: 39819513
PMC: 11884395.
DOI: 10.1523/JNEUROSCI.0647-24.2024.
Johnson N, Cotelo-Larrea A, Stetzik L, Akkaya U, Zhang Z, Gadziola M
Nat Commun. 2025; 16(1):336.
PMID: 39747223
PMC: 11696867.
DOI: 10.1038/s41467-024-55644-6.
Hill J, Korponay C, Salmeron B, Ross T, Janes A
Hum Brain Mapp. 2024; 45(17):e70086.
PMID: 39665506
PMC: 11635694.
DOI: 10.1002/hbm.70086.
Corbi Z, Koch K, Holzel B, Soutschek A
Sci Rep. 2024; 14(1):29526.
PMID: 39604522
PMC: 11603186.
DOI: 10.1038/s41598-024-79137-0.
Neural reward system reflects individual value comparison strategy in cost-benefit decisions.
Corbi Z, Soutschek A
Commun Biol. 2024; 7(1):1488.
PMID: 39533059
PMC: 11557971.
DOI: 10.1038/s42003-024-07210-5.
The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.
Kornelius E, Huang J, Lo S, Huang C, Yang Y
Sci Rep. 2024; 14(1):24433.
PMID: 39424950
PMC: 11489776.
DOI: 10.1038/s41598-024-75965-2.
Apathy and effort-based decision-making in Alzheimer's disease and subjective cognitive impairment.
Attaallah B, Toniolo S, Maio M, Husain M
Alzheimers Dement (Amst). 2024; 16(4):e70013.
PMID: 39416486
PMC: 11480904.
DOI: 10.1002/dad2.70013.
Neural and Computational Mechanisms of Motivation and Decision-making.
Yee D
J Cogn Neurosci. 2024; 36(12):2822-2830.
PMID: 39378176
PMC: 11602011.
DOI: 10.1162/jocn_a_02258.
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).
Khalil I, Sayad R, Kedwany A, Sayed H, Caprara A, Rissardo J
Med Int (Lond). 2024; 4(6):70.
PMID: 39355336
PMC: 11443310.
DOI: 10.3892/mi.2024.194.
Individual differences in decision-making shape how mesolimbic dopamine regulates choice confidence and change-of-mind.
Kocharian A, Redish A, Rothwell P
bioRxiv. 2024; .
PMID: 39345599
PMC: 11429702.
DOI: 10.1101/2024.09.16.613237.
A dopaminergic basis of behavioral control.
Ballard I, Furman D, Berry A, White 3rd R, Jagust W, Kayser A
bioRxiv. 2024; .
PMID: 39345422
PMC: 11429830.
DOI: 10.1101/2024.09.17.613524.
A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation.
Treadway M, Etuk S, Cooper J, Hossein S, Hahn E, Betters S
Mol Psychiatry. 2024; .
PMID: 39289477
DOI: 10.1038/s41380-024-02751-x.
Categorical and dimensional aspects of stimulant medication effects in adult patients with ADHD and healthy controls.
Thunberg P, Reingardt M, Rode J, Msghina M
Front Pharmacol. 2024; 15:1412178.
PMID: 39050752
PMC: 11266130.
DOI: 10.3389/fphar.2024.1412178.
Beta and theta oscillations track effort and previous reward in the human basal ganglia and prefrontal cortex during decision making.
Hoy C, de Hemptinne C, Wang S, Harmer C, Apps M, Husain M
Proc Natl Acad Sci U S A. 2024; 121(31):e2322869121.
PMID: 39047043
PMC: 11295073.
DOI: 10.1073/pnas.2322869121.
Gaze-centered gating, reactivation, and reevaluation of economic value in orbitofrontal cortex.
Ferro D, Cash-Padgett T, Wang M, Hayden B, Moreno-Bote R
Nat Commun. 2024; 15(1):6163.
PMID: 39039055
PMC: 11263430.
DOI: 10.1038/s41467-024-50214-2.
Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance.
Kirschner H, Molla H, Nassar M, de Wit H, Ullsperger M
bioRxiv. 2024; .
PMID: 39026741
PMC: 11257491.
DOI: 10.1101/2024.07.04.602054.
Decomposing loss aversion from a single neural signal.
Wang R, Wang X, Platt M, Sheng F
iScience. 2024; 27(7):110153.
PMID: 39006480
PMC: 11245989.
DOI: 10.1016/j.isci.2024.110153.
From movement to motivation: a proposed framework to understand the antidepressant effect of exercise.
Hird E, Slanina-Davies A, Lewis G, Hamer M, Roiser J
Transl Psychiatry. 2024; 14(1):273.
PMID: 38961071
PMC: 11222551.
DOI: 10.1038/s41398-024-02922-y.
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Young C, Cholerton B, Smith A, Shahid-Besanti M, Abdelnour C, Mormino E
Neurology. 2024; 103(2):e209609.
PMID: 38870440
PMC: 11244747.
DOI: 10.1212/WNL.0000000000209609.